CIHI developed the National Prescription Drug Utilization Information System (NPDUIS) Database in consultation with the Patented Medicine Prices Review Board (PMPRB).
The NPDUIS Database houses pan-Canadian information on public drug programs. The database includes the following:
- Claims data — cost and payment information on prescribed drugs. This information is used to measure and analyze prescription drug use in Canada.
- Formulary data — information on which drugs are included in public drug programs in Canada and how they are covered.
- Drug product information — used to identify drug products in a standardized format.
- Plan information — an outline of the administrative policies of public drug plans or programs in Canada. This data may help explain differences in drug utilization patterns across the country.
We welcome your feedback and questions
- Contact us at firstname.lastname@example.org.
Have a data inquiry or research question? Make a custom data request.
Information on the NPDUIS Database
- Prescribed Drug Spending in Canada, 2016: A Focus on Public Drug Programs (Dec. 2016) (formerly Drug Expenditure in Canada)
- National Prescription Drug Utilization Information System Plan Information Document, July 2016
- National Prescription Drug Utilization Information System Database-Plan Information: Summary of Changes, July 2016
- Drug Use Among Seniors on Public Drug Programs in Canada, 2012 (May 2014)
- Drivers of Prescription Drug Spending in Canada (2012) (PDF)
- The Use of Selected Psychotropic Drugs Among Seniors on Public Drug Programs in Canada, 2001 to 2010 (Mar. 2012)
- Privacy Impact Assessment (2011)
Metadata is information about data. It helps users understand and interpret data from a specific source.
Find out more about NPDUIS Database data: